RxDoctor Payments Data

Perth Blake, MD

Family Medicine · Tavares, FLNPI 1063505105

Payments from drug & device makers

$1,639in general payments, 2019–2025

Across 84 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$248
  • Pfizer$238
  • GSK$134
  • Johnson & Johnson$131
  • Lilly USA, LLC$105
  • Edwards Lifesciences$71
  • plus $713 from 21 others

What the payments were for

  • Food & beverage$1,639100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,639 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$97,787
Medicare patients
191
Services billed
1,177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban95$81,198
MounjaroTirzepatide54$56,045
JardianceEmpagliflozin54$53,050
OzempicSemaglutide26$33,438
XareltoRivaroxaban30$20,536
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$19,558
SymbicortBudesonide/Formoterol Fumarate48$14,551
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$12,528
Rosuvastatin Calcium393$5,786
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$4,987
Incruse ElliptaUmeclidinium Bromide12$4,371
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$3,347
NamzaricMemantine Hcl/Donepezil Hcl11$3,160
Albuterol Sulfate HfaAlbuterol Sulfate144$2,994
Famotidine123$2,550

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$238$81,19895 claims
Lilly USA, LLCMounjaro$105$56,04554 claims
Novo NordiskOzempic$43$33,43826 claims
AstraZenecaSymbicort, Breztri Aerosphere$248$27,07865 claims
GSKTrelegy Ellipta, Incruse Ellipta$134$23,92935 claims
Johnson & JohnsonXarelto$131$20,53630 claims
AbbVieNamzaric$62$3,16011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Tavares

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →